Table 2. Multivariable adjusted comparisons of opioid exposure prevalence.
Opioid Prevalence, % |
Opioid Prevalence Ratio (95% confidence interval) |
Non-opioid Prevalence, % |
Non-opioid Prevalence Ratio (95% confidence interval) |
||
---|---|---|---|---|---|
Gender | |||||
Female | 81.3 | 0.99 (0.96, 1.01) | 84.8 | 1.01 (0.99, 1.03) | |
Male | 82.2 | Reference | 84.7 | Reference | |
Age, years | |||||
<1 | 78.2 | 1.06 (0.99, 1.14) | 82.7 | 1.02 (0.96, 1.08) | |
1 to < 5 | 73.8 | Reference | 79.0 | Reference | |
5 to <10 | 78.1 | 1.06 (0.99, 1.12) | 86.5 | 1.07 (1.02, 1.13)* | |
10 to <15 | 87.2 | 1.18 (1.11, 1.26)* | 87.7 | 1.11 (1.05, 1.18)* | |
15 to <20 | 92.9 | 1.26 (1.18, 1.34)* | 88.4 | 1.12 (1.04, 1.20)* | |
Race | |||||
White | 79.8 | Reference | 85.3 | Reference | |
Black | 81.9 | 1.03 (0.98, 1.08) | 80.7 | 1.00 (0.96, 1.04) | |
Asian | 82.6 | 1.03 (0.93, 1.16) | 93.2 | 1.06 (1.00, 1.11) | |
Other | 82.6 | 1.03 (0.99, 1.08) | 83.5 | 1.02 (0.94, 1.11) | |
Insurance | |||||
Private | 80.9 | Reference | 84.6 | Reference | |
Public | 82.2 | 1.01 (0.98, 1.05) | 82.8 | 1.00 (0.96, 1.03) | |
Other | 82.1 | 1.01 (0.96, 1.07) | 90.1 | 1.04 (0.98, 1.12) | |
Total Parenteral Nutrition | |||||
Yes | 88.1 | 1.16 (1.13, 1.20)* | 88.4 | 1.06 (1.01, 1.11)* | |
No | 75.8 | Reference | 83.6 | Reference | |
ICU level care | |||||
Yes | 85.9 | 1.10 (1.07, 1.14)* | 92.1 | 1.04 (1.00, 1.09) | |
No | 77.8 | Reference | 83.9 | Reference |
*p-value <0.05
All models adjusted for presented covariates, chemotherapy course and diagnosis year.